Opis działalności
Grifols S.A., headquartered in Barcelona, Spain, is a global healthcare company with a track-record of more than 75 years improving people’s health and well-being through the development of plasma protein therapies, hospital pharmacy products and diagnostic technology for clinical use. They have three primary divisions: Bioscience, Diagnostic and Hospital. The company is present in more than 100 countries worldwide and its headquarters are located in Barcelona, Spain. Grifols is a leader in plasma collection with a network of 160 plasma donation centers in the U.S., and is a leading producer of plasma-derived medicines. As a recognized leader in transfusion medicine, Grifols offers a comprehensive range of transfusion medicine, hemostasis, and immunoassay solutions for clinical laboratories, blood banks, and transfusion centers.
Zarząd & Rada nadzorcza
| CEO |
| Nacho Abia |
| Zarząd |
| Raimon Grífols Roura, Víctor Grífols Deu, Thomas Glanzmann |
| Rada nadzorcza |
| Belén Villalonga Morenés, Carina Szpilka Lázaro, Enrique Felip Font, Iñigo Sánchez- Asiaín Mardones, James Costos, Marla E.Salmon, Raimon Grífols Roura, Ramon Riera Roca, Steven F. Mayer, Tomás Dagá Gelabert, Víctor Grífols Deu, Víctor Grifols Roura |
Dane firmy
| Nazwa: |
Grifols S.A. |
| Adres: |
Avinguda de la Generalitat, 152, Parque empresarial Can Sant Joan,ES-08174 Sant Cugat del Vallès, Barcelona |
| Telefon: |
+34-93-5712200 |
| Fax: |
+34-93-5710267 |
| E-mail: |
grifols@grifols.com
|
| Internet: |
www.grifols.com |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
Artykuły Medyczne |
| Koniec roku finansowego: |
31.12 |
| Free float: |
100,00% |
| Data IPO: |
- |
